To a 10 mL oven-dried Schlenk tube equipped with a magnetic stirrer, 1 (0.22 mmol, 1.1 equiv.), 2 (0.2 mmol, 1.0 equiv.), and Cu(NO3)2 (5 mol%) were added. Then, the tube was evacuated and backfilled with nitrogen for three times. Then, DMSO (2.0 mL) was added by injection syringe. Finally, the tube was sealed and placed in the photoreactor about 2 cm away from a 30 W 465 nm LEDs light irradiation with a fanner to maintain the temperature at room temperature for 6 h. The reaction mixture was quenched with brine (10 mL) and extracted with EtOAc (5 mL×3). The combined organic extracts were dried (Na2SO4) and concentrated under reduced pressure. The crude product was purified by flash column chromatography [V(PE)∶ V(EtOAc)=1∶2] on silica gel to afford compounds 3 and 4.
tert-Butyl 3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydro-quinazolin-2-yl)propyl)indoline-1-carboxylate (3a): White solid, 67.1 mg, 77% yield, m.p. 93.2~95.1 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.81 (s, 1H), 8.09 (dd, J=8.0, 1.2 Hz, 1H), 7.75 (d, J=8.0 Hz, 1H), 7.69~7.65 (m, 1H), 7.58 (d, J=8.4 Hz, 1H), 7.39 (d, J=7.2 Hz, 1H), 7.37~7.33 (m, 1H), 7.28~7.24 (m, 1H), 7.11~7.07 (m, 1H), 5.55 (s, 1H), 2.89~2.74 (m, 2H), 2.17~2.03 (m, 2H), 2.03~1.91 (m, 2H), 1.55 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 177.9, 163.9, 156.2, 149.0, 148.9, 139.0, 134.9, 129.8, 129.6, 126.9, 126.7, 126.3, 125.0, 124.1, 120.3, 115.3, 84.8, 76.1, 38.1, 35.0, 28.1, 20.7; HRMS (ESI) calcd for C24H26N3O5 [M+H]+ 436.1867, found 436.1865.
2-(3-(1-Acetyl-3-hydroxy-2-oxoindolin-3-yl)propyl)qui-nazolin-4(3H)-one (3b): White solid, 62.9 mg, 67% yield, m.p. 107.4~108.2 ℃ (dec.); 1H NMR (400 MHz, DMSO- d6) δ: 12.14 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.82 (d, J=8.0 Hz, 1H),7.76~7.72 (m, 1H), 7.55~7.50 (m, 3H), 7.46~7.36 (m, 6H), 7.35~7.23 (m, 1H), 6.34 (s, 1H), 5.45 (d, J=12.8 Hz, 1H), 5.39 (d, J=12.4 Hz, 1H), 2.53 (t, J=7.6 Hz, 2H), 2.00~1.89 (m, 2H), 1.62~1.38 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 176.0, 161.8, 156.9, 150.2, 148.8, 138.4, 135.4, 134.3, 130.8, 129.4, 128.6, 128.3, 127.9, 126.8, 126.0, 125.7, 125.0, 124.1, 120.9, 114.6, 75.1, 68.0, 37.6, 34.3, 20.8; HRMS (ESI) calcd for C27H23N3- NaO5 [M+Na]+ 492.1530, found 492.1525.
Benzyl 3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquin-azolin-2-yl)propyl)indoline-1-carboxylate (3c): White solid, 47.8 mg, 63% yield, m.p. 221.3~222.5 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.13 (s, 1H), 8.11 (d, J=8.4 Hz, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.77~7.73 (m, 1H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.42 (m, 2H), 7.39 (td, J=8.0, 1.2 Hz, 1H), 7.29~7.26 (m, 1H), 6.35 (s, 1H), 2.58 (s, 3H), 2.53 (t, J=7.6 Hz, 2H), 2.01~1.90 (m, 2H), 1.64~1.41 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 178.7, 170.5, 161.8, 156.9, 148.8, 139.3, 134.3, 131.1, 129.3, 126.8, 126.0, 125.7, 125.3, 124.0, 120.9, 115.8, 75.3, 37.5, 34.3, 26.4, 20.6; HRMS (ESI) calcd for C21H20N3O4 [M+H]+ 378.1448, found 378.1448.
2-(3-(1-Benzoyl-3-hydroxy-2-oxoindolin-3-yl)propyl)-quinazolin-4(3H)-one (3d): White solid, 58.2 mg, 66% yield, m.p. 190.2~191.0 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.16 (s, 1H), 8.07 (d, J=7.6 Hz, 1H), 7.77~7.73 (m, 4H), 7.67~7.63 (m, 1H), 7.56 (d, J=8.4 Hz, 1H), 7.53~7.49 (m, 3H), 7.46~7.41 (m, 2H), 7.31~7.27 (m, 1H), 6.41 (s, 1H), 2.59 (t, J=7.2 Hz, 2H), 2.06~1.94 (m, 2H), 1.75~1.52 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 177.6, 168.9, 161.8, 156.9, 148.9, 139.2, 134.3, 134.1, 132.9, 131.5, 129.3, 129.2, 128.3, 126.8, 126.0, 125.7, 125.2, 124.3, 120.9, 114.5, 75.5, 37.2, 34.3, 20.7; HRMS (ESI) calcd for C26H22N3O4 [M+H]+ 440.1605, found 440.1602.
2-(3-(3-Hydroxy-2-oxo-1-tosylindolin-3-yl)propyl)quin-azolin-4(3H)-one (3e): White solid, 51.2 mg, 52% yield, m.p. 221.3~222.7 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.08 (s, 1H), 8.07 (d, J=7.6 Hz, 1H), 7.90 (d, J=8.0 Hz, 2H), 7.79~7.74 (m, 2H), 7.54 (d, J=8.4 Hz, 1H), 7.46 (d, J=7.6 Hz, 1H), 7.43~7.38 (m, 2H), 7.36 (d, J=8.0 Hz, 2H), 7.28~7.24 (m, 1H), 6.44 (s, 1H), 2.43 (t, J=7.8 Hz, 2H), 2.22 (s, 3H), 1.91~1.80 (m, 2H), 1.25~1.17 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 176.2, 161.8, 156.7, 148.8, 145.9, 137.7, 134.5, 134.3, 130.6, 130.1, 129.9, 127.4, 126.8, 126.1, 125.7, 125.3, 124.6, 120.8, 113.0, 75.4, 37.9, 34.1, 21.0, 20.6; HRMS (ESI) calcd for C26H24N3O5S [M+H]+ 490.1431, found 490.1421.
tert-Butyl 4-bromo-3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3h): White solid, 82.3 mg, 80% yield, m.p. 259.1~259.5 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.16 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.79~7.72 (m, 2H), 7.54 (d, J=8.0 Hz, 1H), 7.45~7.41 (m, 1H), 7.38 (dd, J=8.0, 1.2 Hz, 1H), 7.32 (t, J=8.0 Hz, 1H), 6.35 (s, 1H), 2.59~2.47 (m, 2H), 2.42 (td, J=12.8, 4.4 Hz, 1H), 1.99 (td, J=12.8, 4.4 Hz, 1H), 1.55 (s, 9H), 1.41~1.14 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 175.1, 161.7, 156.6, 148.8, 148.2, 140.9, 134.2, 131.1, 128.9, 127.9, 126.8, 126.0, 125.6, 120.8, 118.7, 113.8, 84.4, 76.6, 34.2, 34.1, 27.6, 20.8; HRMS (ESI) calcd for C24H25BrN3O5 [M+H]+514.0972, found 514.0977.
tert-Butyl 4-chloro-3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3i): White solid, 83.9 mg, 89% yield, m.p. 150.3~151.8 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.14 (s, 1H), 8.05 (dd, J=8.0, 1.6 Hz, 1H), 7.77~7.72 (m, 2H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.38 (m, 2H), 7.23 (d, J=8.0 Hz, 1H), 6.37 (s, 1H), 2.59~2.45 (m, 2H), 2.35 (td, J=12.8, 4.4 Hz, 1H), 2.03 (td, J=12.8, 4.4 Hz, 1H), 1.56 (s, 9H), 1.42~1.18 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 175.0, 161.8, 156.6, 148.8, 148.2, 140.8, 134.2, 130.9, 130.5, 126.8, 126.4, 126.0, 125.74, 125.67, 120.8, 113.4, 84.4, 76.1, 34.4, 34.1, 27.6, 20.8; HRMS (ESI) calcd for C24H25ClN3O5 [M+H]+ 470.1477, found 470.1479.
tert-Butyl 3-hydroxy-4-methyl-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3j): White solid, 80.5 mg, 89% yield, m.p. 253.4~254.1 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.80 (s, 1H), 8.16 (dd, J=8.0, 1.6 Hz, 1H), 7.71~7.67 (m, 1H), 7.59~7.57 (m, 2H), 7.42~7.38 (m, 1H), 7.13 (t, J=8.0 Hz, 1H), 6.87 (d, J=7.6 Hz, 1H), 4.80 (s, 1H), 2.84~2.71 (m, 2H), 2.42 (s, 3H), 2.34~2.22 (m, 2H), 1.86~1.75 (m, 1H), 1.63~1.50 (m, 10H); 13C NMR (101 MHz, CDCl3) δ: 177.9, 164.0, 156.0, 149.1, 148.9, 139.5, 136.0, 134.9, 129.5, 127.4, 127.0, 126.6, 126.43, 126.35, 120.5, 112.7, 84.8, 77.3, 36.7, 35.1, 28.1, 21.1, 17.8; HRMS (ESI) calcd for C25H28N3O5 [M+H]+ 450.2023, found 450.2029.
tert-Butyl 5-bromo-3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3k): White solid, 77.1 mg, 75% yield, m.p. 137.1~138.9 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.15 (s, 1H), 8.05 (dd, J=7.6, 0.8 Hz, 1H), 7.80~7.71 (m, 2H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.40 (m, 1H), 7.38 (d, J=7.6 Hz, 1H), 7.35~7.29 (m, 1H), 6.34 (s, 1H), 2.61~2.46 (m, 2H), 2.41 (td, J=12.8, 4.4 Hz, 1H), 1.99 (td, J=12.8, 4.4 Hz, 1H), 1.55 (s, 9H), 1.42~1.13 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 175.8, 164.1, 156.1, 148.9, 148.7, 141.2, 135.0, 130.9, 129.3, 127.5, 127.0, 126.7, 126.5, 120.4, 119.1, 114.3, 85.2, 77.6, 34.9, 34.7, 28.1, 20.6; HRMS (ESI) calcd for C24H25BrN3O5 [M+H]+ 514.0972, found 514.0977.
tert-Butyl 3-hydroxy-5-iodo-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3l): White solid, 77.3 mg, 69% yield, m.p. 170.3~171.9 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.15 (s, 1H), 8.05 (d, J=8.0 Hz, 1H), 7.77~7.70 (m, 3H), 7.59~7.53 (m, 2H), 7.46~7.41 (m, 1H), 6.36 (s, 1H), 2.54 (t, J=7.4 Hz, 2H), 2.00~1.83 (m, 2H), 1.57~1.38 (m, 11H); 13C NMR (101 MHz, DMSO-d6) δ: 175.1, 161.8, 156.8, 148.8, 148.4, 138.5, 138.0, 134.2, 133.3, 132.4, 126.8, 126.0, 125.7, 120.9, 117.0, 88.8, 84.1, 74.8, 37.2, 34.2, 27.6, 20.5; HRMS (ESI) calcd for C24H24IN3NaO5 [M+Na]+584.0653, found 584.0651.
tert-Butyl 3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydro-quinazolin-2-yl)propyl)-5-(trifluoromethoxy)indoline-1-carboxylate (3m): White solid, 54.2 mg, 52% yield, m.p. 158.3~159.6 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.90 (s, 1H), 8.10 (dd, J=8.0, 1.2 Hz, 1H), 7.83 (d, J=8.8 Hz, 1H), 7.72~7.66 (m, 1H), 7.60 (d, J=7.9 Hz, 1H), 7.40~7.35 (m, 1H), 7.30 (d, J=2.0 Hz, 1H), 7.19~7.14 (m, 1H), 5.93 (s, 1H), 2.95~2.79 (m, 2H), 2.22~1.95 (m, 4H), 1.55 (s, 9H); 13C NMR (101 MHz, DMSO-d6) δ: 175.5, 161.8, 156.8, 148.8, 148.4, 145.1 (q, JC-F=1.8 Hz), 137.6, 134.2, 132.9, 126.8, 126.0, 125.7, 122.3, 120.9, 120.1 (q, JC-F=257.6 Hz), 117.4, 116.2, 84.2, 74.9, 37.1, 34.2, 27.6, 20.4; 19F NMR (376 MHz, DMSO-d6) δ: -56.09; HRMS (ESI) calcd for C25H24F3N3NaO6 [M+Na]+ 542.1509, found 542.1504.
tert-Butyl 3-hydroxy-5-methoxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3n): White solid, 54.1 mg, 58% yield, m.p. 173.4~174.8 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.13 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.78~7.71 (m, 1H), 7.66 (d, J=8.8 Hz, 1H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.41 (m, 1H), 6.97 (d, J=2.8 Hz, 1H), 6.93 (dd, J=8.8, 2.8 Hz, 1H), 6.27 (s, 1H), 3.75 (s, 3H), 2.53 (t, J=7.6 Hz, 2H), 1.97~1.85 (m, 2H), 1.57~1.31 (m, 11H); 13C NMR (101 MHz, DMSO-d6) δ: 176.1, 161.8, 156.8, 156.6, 148.8, 148.6, 134.3, 132.0, 131.9, 126.8, 126.0, 125.7, 120.8, 115.6, 114.2, 109.9, 83.6, 75.2, 55.5, 37.5, 34.3, 27.7, 20.7; HRMS (ESI) calcd for C25H28N3O6 [M+H]+ 466.1973, found 466.1974.
tert-Butyl 6-bromo-3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3o): White solid, 61.8 mg, 60% yield, m.p.181.3~183.2 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.13 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.92 (d, J=1.6 Hz, 1H), 7.77~7.71 (m, 1H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.40 (m, 2H), 7.36 (d, J=8.0 Hz, 1H), 6.34 (s, 1H), 2.53 (t, J=7.6 Hz, 2H), 1.96~1.85 (m, 2H), 1.62~1.42 (m, 11H); 13C NMR (101 MHz, DMSO-d6) δ: 175.5, 161.8, 156.8, 148.8, 148.4, 140.0, 134.2, 130.0, 127.4, 126.8, 126.0, 125.9, 125.7, 121.8, 120.9, 117.5, 84.3, 74.8, 37.1, 34.3, 27.6, 20.6; HRMS (ESI) calcd for C24H25BrN3O5 [M+H]+514.0972, found 514.0977.
tert-Butyl 3-hydroxy-6-methoxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3p): White solid, 67.1 mg, 72% yield, m.p. 171.7~172.5 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.72 (s, 1H), 8.12 (dd, J=8.0, 1.6 Hz, 1H), 7.72~7.66 (m, 1H), 7.60 (d, J=8.0 Hz, 1H), 7.41~7.35 (m, 2H), 7.28 (d, J=8.4 Hz, 1H), 6.61 (dd, J=8.4, 2.4 Hz, 1H), 5.07 (s, 1H), 3.75 (s, 3H), 2.89~2.74 (m, 2H), 2.17~2.01 (m, 2H), 2.00~1.86 (m, 2H), 1.56 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 178.1, 163.9, 161.0, 156.2, 149.1, 149.0, 140.4, 134.9, 127.1, 126.7, 126.4, 124.9, 121.3, 120.4, 110.5, 102.1, 84.8, 75.9, 55.6, 38.1, 35.2, 28.1, 20.9; HRMS (ESI) calcd for C25H28N3O6 [M+H]+ 466.1973, found 466.1974.
tert-Butyl 7-fluoro-3-hydroxy-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3q): White solid, 41.8 mg, 46% yield, m.p. 115.4~116.8 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.15 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.77~7.73 (m, 1H), 7.55 (d, J=7.6 Hz, 1H), 7.46~7.42 (m, 1H), 7.32~7.25 (m, 3H), 6.50 (s, 1H), 2.53 (t, J=7.6 Hz, 2H), 1.96~1.88 (m, 2H), 1.59~1.36 (m, 2H), 1.50 (s, 9H); 13C NMR (101 MHz, DMSO-d6) δ: 175.9, 161.8, 156.8, 148.8, 148.0 (d, JC-F=250.5 Hz), 147.0, 134.3, 134.1 (d, JC-F=0.9 Hz), 126.8, 126.3 (d, JC-F=7.1 Hz), 126.0, 125.7, 125.3 (d, JC-F=10.1 Hz), 120.8, 120.1(d, JC-F=3.0 Hz), 117.4 (d, JC-F=20.2 Hz), 84.3, 75.9, 37.6, 34.2, 27.3, 20.6; 19F NMR (376 MHz, DMSO-d6) δ: -119.74; HRMS (ESI) calcd for C24H25FN3O5 [M+H]+ 454.1773, found 454.1774.
tert-Butyl 3-hydroxy-7-methyl-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl) propyl) indoline-1-carboxylate (3r): White solid, 41.4 mg, 46% yield, m.p. 138.5~139.7 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.70 (s, 1H), 8.13 (dd, J=8.0, 1.2 Hz, 1H), 7.73~7.69 (m, 1H), 7.62 (d, J=8.0 Hz, 1H), 7.41~7.37 (m, 1H), 7.23 (d, J=7.2 Hz, 1H), 7.09 (d, J=7.2 Hz, 1H), 7.03 (t, J=7.6 Hz, 1H), 5.16 (s, 1H), 2.90 -2.74 (m, 2H), 2.19 (s, 3H), 2.14~1.88 (m, 4H), 1.54 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 178.5, 163.9, 156.0, 149.1, 149.0, 137.6, 135.0, 132.8, 130.8, 127.1, 126.8, 126.4, 125.0, 124.0, 121.7, 120.4, 85.1, 76.8, 38.1, 35.1, 27.9, 20.7, 19.7; HRMS (ESI) calcd for C25H28N3O5 [M+H]+ 450.2024, found 450.2029.
tert-Butyl 4-bromo-3-hydroxy-5-methyl-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3s): White solid, 92.8 mg, 88% yield, m.p. 210.3~211.2 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.12 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.76~7.72 (m, 1H), 7.67 (d, J=8.0 Hz, 1H), 7.53 (d, J=8.0 Hz, 1H), 7.45~7.41 (m, 1H), 7.36 (d, J=8.4 Hz, 1H), 6.28 (s, 1H), 2.57~2.43 (m, 3H), 2.30 (s, 3H), 1.98 (td, J=12.8, 4.4 Hz, 1H), 1.55 (s, 9H), 1.40~1.13 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 175.2, 161.8, 156.6, 148.8, 148.2, 138.6, 134.2, 134.1, 131.3, 128.1, 126.8, 126.0, 125.7, 121.3, 120.9, 113.6, 84.2, 77.1, 34.11, 34.07, 27.6, 21.9, 20.8; HRMS (ESI) calcd for C25H26BrN3NaO5 [M+Na]+550.0948, found 550.0951.
tert-Butyl 3-hydroxy-5,7-dimethyl-2-oxo-3-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (3t): White solid, 58.4 mg, 63% yield, m.p. 147.6~148.4 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.13 (s, 1H), 8.05 (dd, J=8.0, 1.2 Hz, 1H), 7.78~7.73 (m, 1H), 7.54 (d, J=8.0 Hz, 1H), 7.46~7.42 (m, 1H), 7.00 (d, J=8.4 Hz, 2H), 6.28 (s, 1H), 2.57~2.45 (m, 2H), 2.26 (s, 3H), 2.10 (s, 3H), 1.93~1.82 (m, 2H), 1.54~1.28 (m, 2H), 1.50 (s, 9H); 13C NMR (101 MHz, DMSO-d6) δ: 177.2, 161.7, 156.9, 148.9, 148.8, 135.0, 134.3, 133.8, 132.4, 131.7, 126.8, 126.0, 125.7, 122.8, 121.9, 120.8, 84.1, 75.9, 37.9, 34.3, 27.4, 21.0, 20.5, 18.6; HRMS (ESI) calcd for C26H30N3O5 [M+H]+464.2180, found 464.2188.
tert-Butyl 3-hydroxy-3-(3-(7-methyl-4-oxo-3,4-dihydro-quinazolin-2-yl)propyl)-2-oxoindoline-1-carboxylate (4a): White solid, 44.2 mg, 49% yield, m.p. 161.2~162.0 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.87 (s, 1H), 7.97 (d, J=8.0 Hz, 1H), 7.77 (d, J=8.0 Hz, 1H), 7.40 (d, J=6.4 Hz, 1H), 7.35 (br s, 1H), 7.28~7.24 (m, 1H), 7.17~7.15 (m, 1H), 7.11~7.07 (m, 1H), 5.78 (s, 1H), 2.87~2.75 (m, 2H), 2.42 (s, 3H), 2.16~2.04 (m, 2H), 2.01~1.94 (m, 2H), 1.54 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 177.9, 163.9, 156.2, 149.0, 145.9, 139.1, 129.7, 128.2, 126.6, 126.1, 124.9, 124.1, 117.9, 115.3, 84.6, 76.1, 38.0, 34.9, 28.1, 22.0, 20.6; HRMS (ESI) calcd for C25H28N3O5 [M+H]+450.2023, found 450.2029.
tert-Butyl 3-hydroxy-3-(3-(8-methyl-4-oxo-3,4-dihydro-quinazolin-2-yl)propyl)-2-oxoindoline-1-carboxylate (4b): White solid, 49.5 mg, 55% yield, m.p. 180.5~181.2 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.91 (s, 1H), 8.01 (d, J=7.6 Hz, 1H), 7.80 (d, J=8.4 Hz, 1H), 7.55 (d, J=7.2 Hz, 1H), 7.42 (d, J=6.8 Hz, 1H), 7.33~7.28 (m, 2H), 7.16~7.12 (m, 1H), 5.02 (s, 1H), 2.97~2.81(m, 2H), 2.56 (s, 3H), 2.21~2.02 (m, 2H), 2.01~1.92 (m, 2H), 1.59 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 177.8, 164.7, 154.4, 149.1, 147.7, 139.2, 135.8, 135.6, 129.8, 129.4, 126.1, 125.0, 124.2, 124.0, 120.2, 115.4, 84.8, 76.4, 37.7, 34.8, 28.2, 20.6, 17.9; HRMS (ESI) calcd for C25H28N3O5 [M+H]+ 450.2023, found 450.2029.
tert-Butyl 3-(3-(6-fluoro-4-oxo-3,4-dihydroquinazolin- 2-yl)propyl)-3-hydroxy-2-oxoindoline-1-carboxylate (4c): White solid, 52.7 mg, 58% yield, m.p. 163.2~165.1 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.80 (s, 1H), 7.80 (d, J=8.0 Hz, 1H), 7.62 (dd, J=8.8, 4.8 Hz, 1H), 7.56 (dd, J=8.2, 3.0 Hz, 1H), 7.44~7.39 (m, 2H), 7.33~7.29 (m, 1H), 7.18~7.14 (m, 1H), 5.44 (s, 1H), 2.91~2.74 (m, 2H), 2.15~1.97 (m, 4H), 1.52 (s, 9H); 13C NMR (101 MHz, DMSO-d6) δ: 176.1, 161.2 (d, JC-F=3.3 Hz), 159.6 (d, JC-F=245.4 Hz), 156.3, 148.6, 145.7, 138.7, 130.6, 129.6 (d, JC-F=9.1 Hz), 129.3, 124.7, 124.1, 122.7 (d, JC-F=24.2 Hz), 122.0 (d, JC-F=8.1 Hz), 114.5, 110.3 (d, JC-F=23.2 Hz), 83.8, 74.9, 37.4, 34.2, 27.7, 20.7; 19F NMR (376 MHz, DMSO-d6) δ: -113.41; HRMS (ESI) calcd for C24H24FN3- NaO5 [M+Na]+ 476.1592, found 476.1591.
tert-Butyl 3-(3-(6-chloro-4-oxo-3,4-dihydroquinazolin- 2-yl)propyl)-3-hydroxy-2-oxoindoline-1-carboxylate (4d): White solid, 40.4 mg, 43% yield, m.p. 158.2~159.3 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.80 (s, 1H), 7.85 (d, J=2.0 Hz, 1H), 7.82 (d, J=8.0 Hz, 1H), 7.64 (dd, J=8.8, 2.4 Hz, 1H), 7.57 (d, J=8.8 Hz, 1H), 7.44 (dd, J=7.6, 1.6 Hz, 1H), 7.35~7.31 (m, 1H), 7.20~7.16 (m, 1H), 5.41 (s, 1H), 2.93~2.71 (m, 2H), 2.14~2.00 (m, 4H), 1.50 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 178.8, 162.7, 156.3, 149.0, 147.5, 139.1, 135.5, 132.4, 130.0, 129.3, 128.7, 125.5, 125.2, 124.4, 121.1, 115.5, 85.0, 76.3, 38.0, 35.1, 28.1, 20.8; HRMS (ESI) calcd for C24H25ClN3O5 [M+H]+470.1477, found 470.1480.
tert-Butyl 3-(3-(7-chloro-4-oxo-3,4-dihydroquinazolin- 2-yl)propyl)-3-hydroxy-2-oxoindoline-1-carboxylate (4e): White solid, 48.9 mg, 52% yield, m.p. 154.3~155.8 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.27 (s, 1H), 8.03 (d, J=8.4 Hz, 1H), 7.73 (d, J=8.4 Hz, 1H), 7.58 (d, J=2.0 Hz, 1H), 7.46 (dd, J=8.4, 2.0 Hz, 1H), 7.41~7.36 (m, 2H), 7.24~7.20 (m, 1H), 6.26 (s, 1H), 2.53 (t, J=7.6 Hz, 2H), 1.96~1.85 (m, 2H), 1.56~1.38 (m, 11H); 13C NMR (101 MHz, DMSO-d6) δ: 176.0, 161.2, 158.6, 149.9, 148.6, 138.9, 138.7, 130.6, 129.3, 127.8, 126.3, 125.9, 124.6, 124.1, 119.7, 114.5, 83.8, 74.9, 37.4, 34.3, 27.7, 20.6; HRMS (ESI) calcd for C24H24ClN3KO5 [M+K]+508.1036, found 508.1033.
tert-Butyl 3-(3-(6-bromo-4-oxo-3,4-dihydroquinazolin- 2-yl)propyl)-3-hydroxy-2-oxoindoline-1-carboxylate (4f): White solid, 51.6 mg, 50% yield, m.p. 184.3~185.3 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.71 (s, 1H), 8.02 (d, J=2.4 Hz, 1H), 7.83 (d, J=8.0 Hz, 1H), 7.79 (dd, J=8.4, 2.4 Hz, 1H), 7.50 (d, J=8.4 Hz, 1H), 7.44 (dd, J=7.6, 0.8 Hz, 1H), 7.35~7.31 (m, 1H), 7.21~7.17 (m, 1H), 5.38 (s, 1H), 2.92~2.70 (m, 2H), 2.14~1.99 (m, 4H), 1.51 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 178.9, 162.4, 156.6, 148.9, 147.7, 139.1, 138.3, 130.0, 129.3, 128.8, 128.7, 125.2, 124.4, 121.4, 120.3, 115.5, 85.0, 76.4, 38.0, 35.1, 28.1, 20.8; HRMS (ESI) calcd for C24H25BrN3O5 [M+H]+514.0972, found 514.0977.
tert-Butyl 3-hydroxy-3-(3-(6-methoxy-4-oxo-3,4-di- hydro quinazolin-2-yl)propyl)-2-oxoindoline-1-carboxylate (4g): White solid, 52.2 mg, 56% yield, m.p. 177.3~178.2 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 11.64 (s, 1H), 7.83 (d, J=8.4 Hz, 1H), 7.55 (d, J=8.8 Hz, 1H), 7.43 (d, J=7.6 Hz, 1H), 7.34~7.31 (m, 2H), 7.28~7.25 (m, 1H), 7.19~7.15 (m, 1H), 5.68 (s, 1H), 3.83 (s, 3H), 2.93~2.73 (m, 2H), 2.18~2.03 (m, 4H), 1.51 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 178.8, 163.5, 158.0, 153.6, 149.0, 143.7, 139.1, 129.8, 129.5, 128.4, 125.2, 125.0, 124.4, 120.8, 115.4, 105.5, 84.8, 76.3, 55.8, 38.0, 34.9, 28.1, 20.9; HRMS (ESI) calcd for C25H28N3O6 [M+H]+ 466.1973, found 466.1974.
tert-Butyl 3-hydroxy-3-(3-(3-methyl-4-oxo-3,4-dihy-droquinazolin-2-yl)propyl)-2-oxoindoline-1-carboxylate (4h): White solid, 41.2 mg, 46% yield, m.p. 110.3~112.1 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 8.18 (dd, J=8.0, 1.2 Hz, 1H), 7.80 (d, J=8.0 Hz, 1H), 7.70~7.65 (m, 1H), 7.60 (d, J=8.0 Hz, 1H), 7.43~7.39 (m, 2H), 7.34~7.30 (m, 1H), 7.18~7.14 (m, 1H), 5.25 (s, 1H), 3.51 (s, 3H), 2.82 (t, J=6.8 Hz, 2H), 2.12~2.06 (m, 2H), 2.03~1.97 (m, 2H), 1.60 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 177.0, 162.4, 156.3, 149.1, 146.6, 139.1, 134.4, 129.9, 129.8, 126.8, 126.7, 126.6, 124.9, 123.9, 120.1, 115.3, 84.7, 75.8, 37.8, 34.3, 30.3, 28.2, 19.1; HRMS (ESI) calcd for C25H28N3O5 [M+H]+ 450.2023, found 450.2029.
tert-Butyl 3-hydroxy-2-oxo-3-(3-(4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (4i): White solid, 57.4 mg, 56% yield, m.p. 165.4~166.2 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 8.23 (dd, J=8.0, 1.2 Hz, 1H), 7.82 (d, J=8.0 Hz, 1H), 7.77~7.73 (m, 1H), 7.69 (d, J=7.6 Hz, 1H), 7.54~7.44 (m, 4H), 7.36~7.31 (m, 2H), 7.19~7.15 (m, 3H), 4.93 (s, 1H), 2.47~2.37 (m, 2H), 1.99~1.86 (m, 2H), 1.81~1.73 (m, 2H), 1.61 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 176.9, 162.3, 156.2, 149.1, 146.9, 139.2, 137.0, 134.8, 130.09, 130.08, 129.8, 129.7, 129.5, 128.31, 128.29, 127.1, 127.0, 126.8, 124.8, 123.9, 120.8, 115.3, 84.6, 75.9, 37.9, 34.9, 28.2, 19.3; HRMS (ESI) calcd for C30H30N3O5 [M+H]+ 512.2180, found 512.2185.
tert-Butyl 3-hydroxy-2-oxo-3-(3-(4-oxo-3-(p-tolyl)-3,4- dihydroquinazolin-2-yl)propyl)indoline-1-carboxylate (4j): White solid, 51.3 mg, 49% yield, m.p. 129.3~131.1 ℃ (dec.); 1H NMR (400 MHz, CDCl3) δ: 8.26 (dd, J=8.0, 1.2 Hz, 1H), 7.85 (d, J=8.0 Hz, 1H), 7.78~7.74 (m, 1H), 7.71 (dd, J=8.0, 0.8 Hz, 1H), 7.49~7.45 (m, 1H), 7.38~7.31 (m, 4H), 7.20~7.16 (m, 1H), 7.06 (d, J=8.0 Hz, 2H), 5.00 (s, 1H), 2.49~2.43 (m, 5H), 2.01~1.82 (m, 4H), 1.62 (s, 9H); 13C NMR (101 MHz, CDCl3) δ: 177.0, 162.5, 156.5, 149.2, 146.9, 139.6, 139.2, 134.8, 134.3, 130.80, 130.78, 129.9, 129.7, 127.99, 127.96, 127.2, 127.0, 126.8, 124.9, 123.9, 120.8, 115.4, 84.6, 75.9, 37.9, 34.9, 28.2, 21.4, 19.2; HRMS (ESI) calcd for C31H32N3O5 [M+H]+526.2336, found 526.2329.
2-(3-(3-Hydroxy-2-oxoindolin-3-yl)propyl)quinazolin-4(3H)-one (6): White solid, 72.2 mg, 87% yield, m.p. 235.6~237.1 ℃ (dec.); 1H NMR (400 MHz, DMSO-d6) δ: 12.13 (s, 1H), 10.26 (s, 1H), 8.05 (d, J=6.8 Hz, 1H), 7.77~7.72 (m, 1H), 7.55 (d, J=8.0 Hz, 1H), 7.46~7.42 (m, 1H), 7.25 (d, J=7.2 Hz, 1H), 7.21~7.18 (m, 1H), 6.98~6.94 (m, 1H), 6.80 (d, J=7.6 Hz, 1H), 5.90 (s, 1H), 2.52 (t, J=7.6 Hz, 2H), 1.90~1.75 (m, 2H), 1.60~1.37 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 179.3, 161.8, 157.1, 148.9, 141.7, 134.3, 132.0, 129.0, 126.8, 126.0, 125.7, 124.0, 121.7, 120.8, 109.6, 75.5, 37.2, 34.5, 21.0. HRMS (ESI) calcd for C19H17N3NaO3 [M+Na]+ 358.1162, found 358.1167.
Methyl 2-hydroxy-5-(4-oxo-3,4-dihydroquinazolin-2-yl)-2-phenylpentanoate (8): White solid, 31.9 mg, 45% yield, m.p. 151.3~152.9 ℃; 1H NMR (400 MHz, DMSO- d6) δ: 12.18 (s, 1H), 8.07 (d, J=7.6 Hz, 1H), 7.78~7.74 (m, 1H), 7.58 (d, J=8.0 Hz, 1H), 7.49~7.43 (m, 3H), 7.34~7.31 (m, 2H), 7.27~7.23 (m, 1H), 5.99 (s, 1H), 3.60 (s, 3H), 2.57 (t, J=7.2 Hz, 2H), 2.16~1.98 (m, 2H), 1.70~1.60 (m, 2H); 13C NMR (101 MHz, DMSO-d6) δ: 174.5, 161.8, 157.2, 148.9, 142.4, 134.3, 128.0, 127.3, 126.8, 126.0, 125.7, 125.4, 120.8, 77.8, 52.2, 38.8, 34.4, 21.3; HRMS (ESI) calcd for C20H21N2O4 [M+H]+ 353.1496, found 353.1500.
2-(3-((2,2,6,6-Tetramethylpiperidin-1-yl)oxy)propyl)-quinazolin-4(3H)-one (9): White solid, 39.6 mg, 57% yield, m.p. 145.9~146.7 ℃; 1H NMR (400 MHz, CDCl3) δ: 11.86 (s, 1H), 8.28 (dd, J=8.0, 1.2 Hz, 1H), 7.78~7.74 (m, 1H), 7.68 (d, J=7.6 Hz, 1H), 7.47~7.43 (m, 1H), 3.93 (t, J=6.0 Hz, 2H), 2.95 (t, J=7.6 Hz, 2H), 2.13 (p, J=6.8 Hz, 2H), 1.58~1.40 (m, 6H), 1.16 (s, 6H), 1.10 (s, 6H); 13C NMR (101 MHz, CDCl3) δ: 164.4, 156.9, 149.6, 134.8, 127.2, 126.37, 126.36, 120.7, 75.9, 59.9, 39.7, 33.4, 33.1, 26.5, 20.3, 17.2; HRMS (ESI) calcd for C20H30N3O2 [M+H]+344.2333, found 344.2335.
Supporting Information Optimization conditions; detailed experimental procedures;
1H NMR and
13C NMR spectra for products
3a~
3e,
3h~
3t,
4a~
4j,
6,
8 and
9;
19F NMR spectra for products
3m,
3q and
4c. The Supporting Information is available free of charge via the Internet at
http://sioc-journal.cn/.